- P. Sundgren, Lund/SE ESOI-ESNR: Brain metastases: Imaging after treatment (2021)P. Sundgren, Lund/SE
- K. Lang, Lund/SE ESOI-EUSOBI: Surveillance after breast cancer treatment (2021)K. Lang, Lund/SE
- C. Cyran, Munich/DE ESOI-ESHI-MT: AI in multimodality imaging of cancer (2021)C. Cyran, Munich/DE
- A. Alberich-Bayarri, Valencia/ES Imaging biomarkers in oncology (2020)A. Alberich-Bayarri, Valencia/ES
- L. van den Hauwe, Antwerp/BE Spinal tumours (2020)L. van den Hauwe, Antwerp/BE
- L. Fournier, Paris/FR (Rradiologist); A. S. Bats, Paris/FR (Surgeon) Correlation of radiological images with surgical findings in ovarian peritoneal disease (2019)L. Fournier, Paris/FR (Rradiologist); A. S. Bats, Paris/FR (Surgeon)
- J. Palussiere, Bordeaux/FR Interventional oncological treatment of lung nodules/lung cancer (2019)J. Palussiere, Bordeaux/FR
- M. F. Reiser, Munich/DE New paradigms in scientific publishing (2019)M. F. Reiser, Munich/DE
- M. Lobbes, Sittard-Geleen/NL (Radiologist); M. L. Smidt, Maastricht/NL (Surgeon) Breast cancer: A multidisciplinary approach to imaging in neoadjuvant treatment (2019)M. Lobbes, Sittard-Geleen/NL (Radiologist); M. L. Smidt, Maastricht/NL (Surgeon)
- G. Zamboni, Verona/IT (Radiologist); G. Marchegiani, Verona/IT (Surgeon) Pancreatic cancer: A multidisciplinary approach to imaging (2019)G. Zamboni, Verona/IT (Radiologist); G. Marchegiani, Verona/IT (Surgeon)
- P. M. Sundgren, Lund/SE Assessing response to therapy of brain tumours (2019)P. M. Sundgren, Lund/SE
- C. Cyran, Munich/DE Clinical relevance of PSMA PET/CT: An overview and update (2019)C. Cyran, Munich/DE
- E. Neri, Pisa/IT (Radiologist); A. Alberich Bayarri, Valencia/ES (Telecommunications Engineer) Artificial intelligence in oncologic imaging: Current status and future directions (2019)E. Neri, Pisa/IT (Radiologist); A. Alberich Bayarri, Valencia/ES (Telecommunications Engineer)
- A. Baur-Melnyk, Munich/DE Imaging and response assessment of multiple myeloma (2019)A. Baur-Melnyk, Munich/DE
- R. Beets-Tan, Amsterdam/NL (Radiologist); N. Figueiredo, Lisbon/PT (Surgeon); R. Glynne-Jones, Northwood/UK (Radiation Oncologist) Rectal cancer: A multidisciplinary approach to imaging (2019)R. Beets-Tan, Amsterdam/NL (Radiologist); N. Figueiredo, Lisbon/PT (Surgeon); R. Glynne-Jones, Northwood/UK (Radiation Oncologist)
- M. Krokidis, Cambridge/UK Interventional oncological options for RCC (2019)M. Krokidis, Cambridge/UK
- M. Gollub, New York/US Small bowel tumours (2019)M. Gollub, New York/US
- D. Regge, Turin/IT Immune therapy: Response assessment and toxicity (2019)D. Regge, Turin/IT
- H. P. Schlemmer, Heidelberg/DE (Radiologist); J. P. Radtke, Heidelberg/DE (Urologist) Prostate cancer: A multidisciplinary approach to imaging (2019)H. P. Schlemmer, Heidelberg/DE (Radiologist); J. P. Radtke, Heidelberg/DE (Urologist)
- A. Laghi, Rome/IT Imaging and response assessment of gastrointestinal stromal tumours (2018)A. Laghi, Rome/IT
- F. Lecouvet, Brussels/BE Assessment of the treatment response of bone lesions in cancer patients: Pearls and pitfalls (2018)F. Lecouvet, Brussels/BE
- C. Schaefer-Prokop, Amersfoort/NL Lung cancer screening – what did we learn so far? (2018)C. Schaefer-Prokop, Amersfoort/NL
- Th. Helmberger, Munich/DE Multidisciplinary management of CRC liver metastases (2018)Th. Helmberger, Munich/DE
- J. Dinkel, Munich/DE Imaging after treatment of lung cancer (2018)J. Dinkel, Munich/DE
- M. Maas, Amsterdam/NL Structured reporting in rectal cancer (2018)M. Maas, Amsterdam/NL
- H. Ilhan, Munich/DE Neuroendocrine tumours – radionuclide imaging and therapy   (2018)H. Ilhan, Munich/DE
- M. Laniado, Dresden/DE Diagnosis and staging of oesophageal and gastric cancer (2018)M. Laniado, Dresden/DE
- R. Beets-Tan, Amsterdam/NL (Radiologist); G. Beets, Amsterdam/NL (Surgeon); B. van Triest, Amsterdam/NL (Radiation Oncologist) Rectal cancer: A multidisciplinary approach to imaging (2018)R. Beets-Tan, Amsterdam/NL (Radiologist); G. Beets, Amsterdam/NL (Surgeon); B. van Triest, Amsterdam/NL (Radiation Oncologist)
- G. Cook, London/UK Molecular and hybrid imaging in prostate cancer (2018)G. Cook, London/UK
- Algorithmic approach to the female pelvic mass (2018)
- M. D'Anastasi, Msida/MT Response evaluation in oncology: RECIST 1.1 (2018)M. D'Anastasi, Msida/MT
- J. Camps Herrero, Alzira/ES (Radiologist); R. Ponzone, Turin/IT (Surgeon) Preoperative local staging of breast cancer: Tailoring the surgical treatment (2018)J. Camps Herrero, Alzira/ES (Radiologist); R. Ponzone, Turin/IT (Surgeon)
- M. Bertolotto, Trieste/IT Imaging of testicular tumours (2018)M. Bertolotto, Trieste/IT
- D. Regge, Turin/IT Structured reporting in prostate cancer (2018)D. Regge, Turin/IT
- R. Pozzi Mucelli, Verona/IT Cross-sectional imaging of renal tumours (2018)R. Pozzi Mucelli, Verona/IT
- R. Beets-Tan, Amsterdam/NL (Radiologist); G. Beets, Amsterdam/NL (Surgeon); B. van Triest, Amsterdam/NL (Radiation Oncologist) Rectal cancer: A multidisciplinary approach to imaging (2018)R. Beets-Tan, Amsterdam/NL (Radiologist); G. Beets, Amsterdam/NL (Surgeon); B. van Triest, Amsterdam/NL (Radiation Oncologist)
- C. Granata, Genoa/IT Paediatric abdominal tumours (2017)C. Granata, Genoa/IT
- M. Maas, Amsterdam/NL Diagnostic test studies: How I do it (2017)M. Maas, Amsterdam/NL
- J. Ricke, Munich/DE Current evidence for minimally invasive treatments in HCC (2017)J. Ricke, Munich/DE
- G. Brancatelli, Palermo/IT When to call a lesion an HCC? (2017)G. Brancatelli, Palermo/IT
- V. Goh, London/UK PET-MRI in oncologic imaging – where do we stand? (2017)V. Goh, London/UK
- T. Bäuerle, Erlangen/DE Bone metastases, how should we approach them with imaging? (2017)T. Bäuerle, Erlangen/DE
- H. Vargas, New York/US Imaging of recurrent prostate cancer (2017)H. Vargas, New York/US
- Y. Lakhman, New York/US MR imaging of malignant diseases of the uterus (2017)Y. Lakhman, New York/US
- E. Sala, New York/US Imaging of the treated pelvis: Pearls and pitfalls (2017)E. Sala, New York/US
- S. Nougaret, Montpellier/FR Imaging spectrum of primary and secondary mesenteric neoplasms (2017)S. Nougaret, Montpellier/FR
- M. Mayerhöfer, Vienna/AT Imaging of lymphomas (2017)M. Mayerhöfer, Vienna/AT
- U. Mueller-Lisse, Munich/DE Imaging and differential diagnosis of orbital tumours (2017)U. Mueller-Lisse, Munich/DE
- P. Parizel, Antwerp/BE Imaging of CNS tumours (2017)P. Parizel, Antwerp/BE
- G. Guglielmi, Foggia/IT Imaging of bone tumours (2016)G. Guglielmi, Foggia/IT
- F. Gilbert, Cambridge/UK Tailoring breast imaging surveillance to the woman´s risk (2016)F. Gilbert, Cambridge/UK
- H. Vargas, New York/US Role of MRI in the diagnosis and management of prostate cancer (2016)H. Vargas, New York/US
- H. Hricak, New York/US Staging of ovarian cancer – providing a GPS to patient management (2016)H. Hricak, New York/US
- R. Manfredi, Verona/IT Imaging of biliary tract tumours (2016)R. Manfredi, Verona/IT
- L. Bonomo, Rome/IT Imaging of lung cancer: Implications on management  (2016)L. Bonomo, Rome/IT
- V. Vandecaveye, Leuven/BE Whole body MRI in onology (2016)V. Vandecaveye, Leuven/BE
- M. Mack, Munich/DE Imaging dissemination pathways in head and neck cancer (2016)M. Mack, Munich/DE
- D. Clevert, Munich/DE Contrast-enhanced ultrasound-technical considerations and applications in oncologic imaging (2016)D. Clevert, Munich/DE
- R. Beets-Tan, Amsterdam/NL Staging of rectal cancer with MRI (2016)R. Beets-Tan, Amsterdam/NL
- W. Sommer, Munich/DE Structured oncologic reporting (2015)W. Sommer, Munich/DE
- F. Sardanelli, Milan/IT Update on breast MRI (2015)F. Sardanelli, Milan/IT
- J. Futterer, Nijmengen/NL Imaging the prostate – current status and future developments (2015)J. Futterer, Nijmengen/NL
- G. Zamboni, Verona/IT Cystic and solid pancreatic tumours (2015)G. Zamboni, Verona/IT
- A. Laghi, Latina/IT CT colonography (2015)A. Laghi, Latina/IT
- D. M.J. Lambregts, Maastricht/NL DW in oncologic imaging (2015)D. M.J. Lambregts, Maastricht/NL